Cooperative Agreement U01CA293470
Award Date
9/10/24
Completion Date
8/31/29
Dollars Obligated
$665K
Federal Agency
National Cancer Institute
Federal Grant Program
93.396
Assistance Type
Cooperative Agreement
Place of Performance
Maryland, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $510,431 Project Grant under the Cancer Biology Research (CFDA 93.396) program to The Johns Hopkins University. The grant, effective July 1, 2025 through June 30, 2030, supports comprehensive research to investigate the fundamental biological mechanisms underlying tumor dormancy, metastatic recurrence, and therapeutic resistance in aging melanoma patients. The research aims to uncover how the aging immune microenvironment influences tumor cell...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to the Sloan-Kettering Institute for Cancer Research provides $577,034 in funding to investigate the interplay between the physical properties of the tumor microenvironment and the ability of cytotoxic lymphocytes to recognize and destroy cancer cells. The research will examine how distinct metastatic microenvironments (e.g. rigid bone, soft lung) affect the biomechanics of cancer cells...
This $369,868 Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports research to investigate the functional role of mitochondrial transfer from nerves to breast cancer cells, and how this process impacts cancer metastasis and the generation of cancer stem cells. The project aims to use innovative lineage-tracing techniques to quantify the contribution of nerve-to-cancer mitochondrial transfer to the breast cancer metastasis cascade, and evaluate...
This $895,779 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) aims to advance the science of brain metastases from HER2-positive breast cancer. The key products and services to be delivered under this 7-year grant include: Understanding the fundamental biology and genetic risk factors of HER2-positive breast cancer metastases to the brain through patient tissue-based research. Developing real-time visualization techniques to track cancer cells and...
This Project Grant award of $223,176 from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports research to define the role of stress granules in cancer initiation. The primary awardee, The Children's Hospital Corporation doing business as Boston Children's Hospital, will leverage a humanized zebrafish melanoma model to investigate how stress granules formed in melanoma precursor cells impact tumor development and progression. The research aims to elucidate the...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Research Manpower (CFDA 93.398) program, provides $147,486 to the Sloan-Kettering Institute for Cancer Research to support a 3-year training plan in cellular immunology and mechanobiology. The research aims to investigate how microenvironmental stiffness influences immune vulnerability and metastatic site preference in cancer, with the goal of identifying potential biomarkers and novel treatment...
This Cooperative Agreement award from the National Cancer Institute, a division of the Department of Health and Human Services, provides $380,509 under the Cancer Biology Research program to The Trustees of Columbia University in New York. The award supports research to elucidate the molecular drivers of melanoma liver metastasis and associated resistance to immunotherapies. Specifically, the researchers will characterize a novel preclinical mouse model that recapitulates genomic and...
This Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) provides USD 1,344,022 to investigate the role of respiratory viral infections and inflammation in promoting metastatic outgrowth of breast cancer in the lung. The study aims to determine the mechanisms by which acute respiratory viral infections, including influenza and SARS-CoV-2, can induce the awakening of dormant disseminated cancer cells and lead to metastatic disease. It will also explore how...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $730,398 to the Sloan-Kettering Institute for Cancer Research to investigate the relationship between leptomeningeal cancer cell growth and inflammatory signaling in the leptomeningeal space. The research aims to mechanistically dissect the CXCL1-CXCR2 signaling axis within the leptomeningeal space, identify cancer cell signals that provoke leptomeningeal CXCL1 generation, and...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $1,322,707 to Emory University from August 2024 through June 2029 to investigate the biological and social determinants of psychosocial sequelae among advanced head and neck cancer patients receiving immunotherapy. The key goals are to: 1) understand the psychosocial impacts of immunotherapy on this patient population, including factors like fatigue and depression,...